Despite high vaccination coverage worldwide, pertussis has re-emerged in many countries.
This randomized, controlled, observer-blind phase I study and extension study in Belgium …

BACKGROUND: Although decennial adult boosters of tetanus and diphtheria toxoids are
recommended in Canada and the United States, a second dose of pertussis vaccine is not …

Thailand has incorporated the whole-cell (wP) pertussis vaccine into the expanded program
on immunization since 1977 and has offered the acellular pertussis (aP) vaccine as an …

Introduction: Older children and adults, susceptible to pertussis because of waning
immunity, may serve as a reservoir of infection, leading to severe disease among young …

Two clinical studies were undertaken to evaluate the immunogenicity of an adult-type dTpa
booster vaccine (Boostrix™ by GlaxoSmithKline Biologicals). Blood samples taken prior to …

BACKGROUND: Tdap is recommended for health care personnel (HCP) aged< 65 years
who received tetanus diphtheria or tetanus toxoid immunization (Td/TT)≥ 2 years earlier …

Patients with obstructive airway diseases (OAD), like chronic obstructive pulmonary disease
(COPD) and asthma, may be at increased risk of pertussis infection. Pertussis may also …

An understanding of the antibody persistence elicited by a combined tetanus, diphtheria, 5-
component acellular pertussis, and inactivated poliovirus vaccine (Tdap-IPV) after …

Adult pertussis vaccination is increasingly recommended to control pertussis in the
community. However, there is little data on the duration and kinetics of immunity to pertussis …

Reduced-antigen, combined diphtheria, tetanus, and three-component acellular pertussis
vaccine (Tdap; Boostrix®) is indicated for booster vaccination against diphtheria, tetanus …